Synaptive Medical has raised approximately $5 million in a new round of debt and options financing, according to a recently posted SEC filing.
The Toronto-based company has not yet stated how it plans to spend funds raised in the round.
Synaptive Medical produces medical devices intended to facilitate surgical planning, navigation, robotic automation, digital microscopy and informatics through an interconnected platform, according to its website.
Money in the round came from a single unnamed investor, according to the filing, with the first date of sale noted as having occurred on March 26.
Last month, Synaptive Medical said that it named Sandra Clarke as its new finance chief.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.